BioXcel Therapeutics (BX20.F) Q2 2026 Earnings

11MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-2.45
-1.79
-1.12
-0.45

Details

Expected EPS
-0.45416924999999997
Actual EPS
N/A
Surprise EPS
0.45
Surprise Percent
+100%

Description

BioXcel Therapeutics (BX20.F) will report earnings of for Q2 2026 on May 11, 2026.

0 Comments

Share your thoughts